News
Cardinal Health reported revenue of $1.6 billion in the fourth quarter for its Other segment, which includes at-Home ...
The healthcare conglomerate handily beat on the bottom line in its latest reported quarter, but that's not what the market was paying attention to.
U.S. equities were up at midday, with the Nasdaq and S&P 500 trading at record highs, as consumer inflation rose less than ...
Cardinal Health reported steady fourth-quarter results and a stronger profit outlook for 2026, while expanding its specialty ...
Cardinal Health is making another big move in specialty healthcare, agreeing to acquire Solaris Health for $1.9 billion. The ...
Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results